BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 31111906)

  • 1. Emerging mould infections: Get prepared to meet unexpected fungi in your patient.
    Dellière S; Rivero-Menendez O; Gautier C; Garcia-Hermoso D; Alastruey-Izquierdo A; Alanio A
    Med Mycol; 2020 Feb; 58(2):156-162. PubMed ID: 31111906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-Aspergillus Hyaline Molds: Emerging Causes of Sino-Pulmonary Fungal Infections and Other Invasive Mycoses.
    Jacobs SE; Wengenack NL; Walsh TJ
    Semin Respir Crit Care Med; 2020 Feb; 41(1):115-130. PubMed ID: 32000288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging and less common fungal pathogens.
    Fleming RV; Walsh TJ; Anaissie EJ
    Infect Dis Clin North Am; 2002 Dec; 16(4):915-33, vi-vii. PubMed ID: 12512187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging Issues in Antifungal Resistance.
    Perfect JR; Ghannoum M
    Infect Dis Clin North Am; 2020 Dec; 34(4):921-943. PubMed ID: 33131575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors and mortality in invasive Rasamsonia spp. infection: Analysis of cases in the FungiScope
    Stemler J; Salmanton-García J; Seidel D; Alexander BD; Bertz H; Hoenigl M; Herbrecht R; Meintker L; Meißner A; Mellinghoff SC; Sal E; Zarrouk M; Koehler P; Cornely OA
    Mycoses; 2020 Mar; 63(3):265-274. PubMed ID: 31769549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging Fungal Infections.
    Spallone A; Schwartz IS
    Infect Dis Clin North Am; 2021 Jun; 35(2):261-277. PubMed ID: 34016278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging moulds: epidemiological trends and antifungal resistance.
    Miceli MH; Lee SA
    Mycoses; 2011 Nov; 54(6):e666-78. PubMed ID: 21672045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging Fungal Infections: New Species, New Names, and Antifungal Resistance.
    Wiederhold NP
    Clin Chem; 2021 Dec; 68(1):83-90. PubMed ID: 34969112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newer antifungal therapy for emerging fungal pathogens.
    Steinbach WJ; Perfect JR
    Int J Infect Dis; 2003 Mar; 7(1):5-20. PubMed ID: 12718805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hidden pathogenic potential of environmental fungi.
    de S Araújo GR; Souza W; Frases S
    Future Microbiol; 2017 Dec; 12():1533-1540. PubMed ID: 29168657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in the epidemiological landscape of invasive mould infections and disease.
    Lass-Flörl C; Cuenca-Estrella M
    J Antimicrob Chemother; 2017 Mar; 72(suppl_1):i5-i11. PubMed ID: 28355462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Changing Epidemiology of Invasive Fungal Infections.
    Enoch DA; Yang H; Aliyu SH; Micallef C
    Methods Mol Biol; 2017; 1508():17-65. PubMed ID: 27837497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive mould infections in the ICU setting: complexities and solutions.
    Bassetti M; Bouza E
    J Antimicrob Chemother; 2017 Mar; 72(suppl_1):i39-i47. PubMed ID: 28355466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive fungal infections in neonates: a review.
    Weimer KED; Smith PB; Puia-Dumitrescu M; Aleem S
    Pediatr Res; 2022 Jan; 91(2):404-412. PubMed ID: 34880444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus.
    Pfaller MA; Diekema DJ
    J Clin Microbiol; 2004 Oct; 42(10):4419-31. PubMed ID: 15472288
    [No Abstract]   [Full Text] [Related]  

  • 16. Fungal necrotizing fasciitis, an emerging infectious disease caused by Apophysomyces (Mucorales).
    Chander J; Stchigel AM; Alastruey-Izquierdo A; Jayant M; Bala K; Rani H; Handa U; Punia RS; Dalal U; Attri AK; Monzon A; Cano-Lira JF; Guarro J
    Rev Iberoam Micol; 2015; 32(2):93-8. PubMed ID: 25576377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging fungal pathogens in immunocompromised patients: classification, diagnosis, and management.
    Vartivarian SE; Anaissie EJ; Bodey GP
    Clin Infect Dis; 1993 Nov; 17 Suppl 2():S487-91. PubMed ID: 8274615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Future challenges and chances in the diagnosis and management of invasive mould infections in cancer patients.
    Vehreschild JJ; Koehler P; Lamoth F; Prattes J; Rieger C; Rijnders BJA; Teschner D
    Med Mycol; 2021 Jan; 59(1):93-101. PubMed ID: 32898264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on the diagnosis of invasive fungal infection.
    Ibáñez-Martínez E; Ruiz-Gaitán A; Pemán-García J
    Rev Esp Quimioter; 2017 Sep; 30 Suppl 1():16-21. PubMed ID: 28882009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First case of proven invasive pulmonary infection due to Trichoderma longibrachiatum in a neutropenic patient with acute leukemia.
    Sautour M; Chrétien ML; Valot S; Lafon I; Basmaciyan L; Legouge C; Verrier T; Gonssaud B; Abou-Hanna H; Dalle F; Caillot D
    J Mycol Med; 2018 Dec; 28(4):659-662. PubMed ID: 30477694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.